Patent · US Active

Heterocyclic NF-kB inhibitors

US7601745B2 · kind B2 · utility

7Cited by

1References

2Claims

0Family size

Assignee

4SC AG · DE

Inventors

Johann Leban · Planegg, DE
Harald Schmitt · Hersbruck, DE
Kristina Wolf · Kottgeisering, DE
Stefano Pegoraro · Planegg, DE
Andreas Wuzik · Untermeitingen, DE

Key dates

Filing date	Mar 15, 2006
Grant date	Oct 13, 2009
Priority date	—
Expiry date	Nov 17, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to compounds of the general formula (III) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof,

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.